Literature DB >> 16816139

Cholecystokinin and gastrin receptors.

Marlène Dufresne1, Catherine Seva, Daniel Fourmy.   

Abstract

Cholecystokinin and gastrin receptors (CCK1R and CCK2R) are G protein-coupled receptors that have been the subject of intensive research in the last 10 years with corresponding advances in the understanding of their functioning and physiology. In this review, we first describe general properties of the receptors, such as the different signaling pathways used to exert short- and long-term effects and the structural data that explain their binding properties, activation, and regulation. We then focus on peripheral cholecystokinin receptors by describing their tissue distribution and physiological actions. Finally, pathophysiological peripheral actions of cholecystokinin receptors and their relevance in clinical disorders are reviewed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16816139     DOI: 10.1152/physrev.00014.2005

Source DB:  PubMed          Journal:  Physiol Rev        ISSN: 0031-9333            Impact factor:   37.312


  151 in total

1.  Cholecystokinin is up-regulated in obese mouse islets and expands beta-cell mass by increasing beta-cell survival.

Authors:  Jeremy A Lavine; Philipp W Raess; Donald S Stapleton; Mary E Rabaglia; Joshua I Suhonen; Kathryn L Schueler; James E Koltes; John A Dawson; Brian S Yandell; Linda C Samuelson; Margery C Beinfeld; Dawn Belt Davis; Marc K Hellerstein; Mark P Keller; Alan D Attie
Journal:  Endocrinology       Date:  2010-06-09       Impact factor: 4.736

2.  Differential sensitivity of types 1 and 2 cholecystokinin receptors to membrane cholesterol.

Authors:  Ross M Potter; Kaleeckal G Harikumar; S Vincent Wu; Laurence J Miller
Journal:  J Lipid Res       Date:  2011-10-21       Impact factor: 5.922

Review 3.  Gut hormones as potential new targets for appetite regulation and the treatment of obesity.

Authors:  Benjamin C T Field; Alison M Wren; Dunstan Cooke; Stephen R Bloom
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 4.  Obesity treatment: novel peripheral targets.

Authors:  Benjamin C T Field; Owais B Chaudhri; Stephen R Bloom
Journal:  Br J Clin Pharmacol       Date:  2009-12       Impact factor: 4.335

5.  Monitoring the state of cholecystokinin receptor oligomerization after ligand binding using decay of time-resolved fluorescence anisotropy.

Authors:  Kaleeckal G Harikumar; Laurence J Miller
Journal:  Ann N Y Acad Sci       Date:  2008-11       Impact factor: 5.691

Review 6.  Progress in developing cholecystokinin (CCK)/gastrin receptor ligands that have therapeutic potential.

Authors:  Marc J Berna; Jose A Tapia; Veronica Sancho; Robert T Jensen
Journal:  Curr Opin Pharmacol       Date:  2007-11-09       Impact factor: 5.547

7.  CI-988 Inhibits EGFR Transactivation and Proliferation Caused by Addition of CCK/Gastrin to Lung Cancer Cells.

Authors:  Terry W Moody; Bernardo Nuche-Berenguer; Paola Moreno; Robert T Jensen
Journal:  J Mol Neurosci       Date:  2015-03-12       Impact factor: 3.444

Review 8.  The production and role of gastrin-17 and gastrin-17-gly in gastrointestinal cancers.

Authors:  Jeffrey Copps; Richard F Murphy; Sándor Lovas
Journal:  Protein Pept Lett       Date:  2009       Impact factor: 1.890

9.  Vagal afferent fibres determine the oxytocin-induced modulation of gastric tone.

Authors:  Gregory M Holmes; Kirsteen N Browning; Tanja Babic; Samuel R Fortna; F Holly Coleman; R Alberto Travagli
Journal:  J Physiol       Date:  2013-04-15       Impact factor: 5.182

10.  Expression of Reg family proteins in embryonic stem cells and its modulation by Wnt/beta-catenin signaling.

Authors:  Donghui Jing; Daniel E Kehoe; Emmanuel S Tzanakakis
Journal:  Stem Cells Dev       Date:  2010-09       Impact factor: 3.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.